ab64613 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab64613 は 8 報の論文で使用されています。

  • Ballantyne LL  et al. Liver-specific knockout of arginase-1 leads to a profound phenotype similar to inducible whole body arginase-1 deficiency. Mol Genet Metab Rep 9:54-60 (2016). IHC-P, IF ; Mouse . PubMed: 27761413
  • Yu D  et al. Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma. Oncotarget 6:7619-31 (2015). IHC ; Human . PubMed: 25844758
  • Chien WW  et al. Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines. Sci Rep 5:8068 (2015). WB ; Human . PubMed: 25626693
  • Wang C  et al. Long-term supranutritional supplementation with selenate decreases hyperglycemia and promotes fatty liver degeneration by inducing hyperinsulinemia in diabetic db/db mice. PLoS One 9:e101315 (2014). WB . PubMed: 24983750
  • Gruol DL  et al. Increased astrocyte expression of IL-6 or CCL2 in transgenic mice alters levels of hippocampal and cerebellar proteins. Front Cell Neurosci 8:234 (2014). WB ; Mouse . PubMed: 25177271
  • Gu L  et al. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina. Invest Ophthalmol Vis Sci 55:8208-22 (2014). PubMed: 25335981
  • Huang JF  et al. Differential neuronal expression of receptor interacting protein 3 in rat retina: involvement in ischemic stress response. BMC Neurosci 14:16 (2013). IHC-FoFr ; Rat . PubMed: 23374330
  • Ehsanipour EA  et al. Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine. Cancer Res 73:2998-3006 (2013). Human . PubMed: 23585457

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"